Loading clinical trials...
Loading clinical trials...
The proposed study is a bidirectional analytical study, composed of a retrospective and a prospective cohorts. Patients with stage II - III colorectal cancer undergoing oncological surgery will be analyzed. The study will include a convenience sample of 100 individuals. Fifty cases will be included retrospectively and fifty prospectively. The study aims to evaluate the benefit of using the Immunoscore test as a predictor of recurrence in patients with operated stage II-III colon tumors. It will also be evaluated the impact on oncologic decision and costs.
Age
All ages
Sex
ALL
Healthy Volunteers
No
Instituto D'Or de Pesquisa e Ensino - Brasília
Brasília, Federal District, Brazil
Instituto D'Or de Pesquisa e Ensino - Rio de Janeiro
Rio de Janeiro, Brazil
Start Date
April 1, 2022
Primary Completion Date
December 30, 2022
Completion Date
December 30, 2023
Last Updated
June 16, 2022
100
ESTIMATED participants
Immunoscore Colon Test
DIAGNOSTIC_TEST
Lead Sponsor
D'Or Institute for Research and Education
Collaborators
NCT06017141
NCT04963283
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT02863107